A market research report on
10 Healthcare
Players aiming
Beyond Health
Equality to Conquer
Health Equity
What would this Report Cover?
1. Health Equity: A Virtuous Cycle 2. Factors Manifesting Health Equity 3. Healthcare Players Aiming Healthcare Equity
• Bayer
• Gilead
• Sanofi
• Bristol Myers Squibb
• Johnson & Johnson
• Merck
• Pfizer
• AstraZeneca
• Takeda
• Biogen
2
1. Health Equity: A Virtuous Cycle
Pharmaceutical and life sciences companies has unlocked new opportunities, help underserved patients, and
build a cycle of trust to drive a virtuous cycle
1. Analyse (High Quality Data) 1.
Consider the information and data we have now Analyse
2. Expand (Problem Solving)
Consider whose problems we have been solving 4.
Health
2.
Equity
Engage
Expand
3. Challenge (Targeted Approaches) Consider why some groups are not receiving the appropriate medicine or therapy at the right time
3.
4. Engage (Better Collaboration) Challenge
Consider whom else we can collaborate with to fill the identified gaps, & how we can encourage more people to receive needed care 3
2. Factors Manifesting Health Equity
Intricately complicated health disorders can progress, and access disparities, unmet needs, or marginalized
communities can all be signs of health inequities
Lack of adequate alignment between innovation initiatives and the global burden of Unmet Needs
disease
Patients who are unable to access or afford needs like wholesome food, suitable Limited Access
treatment, or essential medications Health
Equity
Underserved
Determinants of ecological health (including payers and providers) failing to engage Communities
groups appropriately for the needs of group members 4
3. Healthcare Players Aiming Healthcare Equity (1/5) Bayer
Gilead
▪ Bayer’s U.S. business nabbed a perfect score from the
▪ Gilead repurposing Ebola drug remdesivir as the first Human Rights Campaign Foundation’s Corporate treatment for COVID boosted its overall reputation last Equality Index
year
▪ Helps boost the overall ranking from alva for the
▪ Gilead launched Zeroing In: Ending the HIV Epidemic, company, which also has a major focus on food and which gifted $24 million in grants to 116 organizations nutrition and agriculture
in 41 countries to tackle the problem on the ground
▪ Bayer also works with the new Women in STEM
▪ The company wants to hire or promote 200 Black leadership pilot program across 12 countries that the Americans without a four-year degree while also Pistoia Alliance recently announced increasing Hispanic representation to 15% of its U.S.
workforce and 3.7% of leadership roles and boosting female leadership representation to 39%
5
3. Healthcare Players Aiming Healthcare Equity (2/5) Sanofi
Bristol Myers Squibb
▪ The Paris-based company has launched an Employee
▪ BMS has been at the forefront of the fight to boost Resource Group (ERG) framework in which voluntary, diversity by issuing $7.9Mn of health equity grants to employee-led ERGs will focus on five areas—gender, 24 U.S. nonprofit organizations aimed at improving generations, pride, ability and culture and origins access and quality care to medically underserved patients and communities
▪ Sanofi’s DE&I strategy 2025 goals revolve around three key pillars: building representative leadership,
▪ BMS until 2025 will accelerate five diversity and creating a work environment where employees can inclusion and health equity commitments—addressing bring their whole selves and engaging with the disparities in healthcare, increasing diversity in clinical company’s diverse communities
trials, expanding supplier diversity, enhancing employee giving to social justice organizations and increasing workforce representation 6
3. Healthcare Players Aiming Healthcare Equity (3/5) Johnson & Johnson
Merck
▪ 2022 was Year 1 of the pharma’s Health for Humanity
▪ To boost diversity in its clinical trials, Merck is working 2025 plan
to build new partnerships with organizations like Black Health Matters, the National Urban League and the
▪ The program comes with 20 key goals like boosting Lazarex Cancer Foundation
women in management, greater diversity in senior teams and improving health equity by developing
▪ The company granted voluntary licenses to several treatments for underserved HIV and tuberculosis Indian generic manufacturers in an effort to boost the patient communities
availability of molnupiravir in India and in other low-and middle-income countries
▪ By 2025, the pharma has pledged to have 50% of management positions globally made up of women
▪ Also teamed up with Johnson & Johnson to scale up and also 35% ethnic/racial diversity in U.S.
production of J&J's single-shot COVID vaccine to help management positions
expand global access
7
3. Healthcare Players Aiming Healthcare Equity (4/5) Pfizer
AstraZeneca
▪ Pfizer recently teamed up with trial site network
▪ The Anglo-Swedish Big Pharma's strategy includes Headlands Research to break ground on several new two 2025 goals: to reach gender equality in research sites in diversely populated areas. A new management positions and to launch supplier diversity Headlands facility is set to take root in Brownsville, programs in 10 new countries outside the US
Texas—a city of about 180,000 on the border of Mexico
▪ AstraZeneca also participates in the Pistoia Alliance’s new Women in STEM leadership pilot program to
▪ Pfizer has joined the Paradigm for Parity coalition, enable leadership and mentoring skill development aiming to achieve “full gender parity” by 2030, with a while furthering workplace diversity near-term goal of women holding at least 30% of senior roles
8
3. Healthcare Players Aiming Healthcare Equity (4/5) Takeda
Biogen
▪ Takeda launched the Center for Health Equity and
▪ Biogen created a new four-point plan to focus on Patient Affairs (HEPA) as a center of excellence in building a more diverse workforce “at all levels” as well 2021 and hopes to make it a leader in health equity as “building awareness, capability and a sustained and patient centricity to “create a more inclusive urgency to act”
ecosystem and strengthen trust and reputation with patients and other key external stakeholders around the world
▪ Takeda is also looking to roll out an enterprise-wide Candidate Relationship Management tool connected with an Applicant Tracking System that it hopes will
“create inclusive talent communities”
9
Who should buy this report?
Pharmaceutical
HealthTech
Digital Health
MedTech
Other Lifesciences
Players
Companies
Entities
Players
Companies
Topics of Upcoming Reports
Will the Expiry of Humira Market Exclusivity and Entry of its Biosimilars Move the Needle in BioPharma Market?
Cost of this report:
$2,500
Metaverse: Paving the way for Health 4.0
Annual Subscription:
Patient Engagement- a New Standpoint on Care that is Patient-Centered
$125,000 $60,000
(Includes a total of 50 reports) E-Rx, the Digital Version of Prescription Improvising the Chances of Better Patient Outcomes Integration of Healthcare Systems with Big Data and Data Silos
Methodology & Scope
Research Methodology
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn) 13
A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages: Market Data Analysis
Interpretation &
Data Collection
& Statistical Model
Presentation
Analysis &
Market Trends
Interpretation
Secondary
Research
Market Sizing &
Insights
Analysis
Primary
Research
Data Triangulation &
Presentation &
Validation
Reporting
14
A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Data Triangulation & Data Validation Top Down Approach
Final
Final Market size break up to
Market
rest of segmentation
Size
Validation from
Arriving at market size
Primary Interview
of each segment
Summarization of revenue
generated from companies
Validation from
to arrive at total market size Primary Interview
Revenue generated by products & Final
services offered by companies
Summary
Bottom Up Approach
15
A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors 16
A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn) Base Year for
2021
Estimation
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage
Company Profiles, Competitive Landscape, Regulatory Landscape, Future Opportunities Report Customization (5 working days) with purchase. We will provide you with data that is Customized Report
currently not a part of our scope as a part of 2022-Forecast
customization
2030
Period
Pricing and purchase
Avail customized purchase options to meet options
your exact research needs
What kind of Data is Presented
in this Report?
This report presents data, which is: Reliable
Expert-verified
Real
Comprehensive
Easy to read
The report is prepared
The data is prepared by
Allowing you to
Covers everything you
You do not have to be a
using a proven
a team of highly qualified
confidently make
would need to know
market expert to
methodology and
& experienced research
smarter business
about the market
understand what really is
insightful research
analysts & vetted by our
and strategic
including market size,
happening on the market
local associates
decisions
competitive analysis &
and how it works
much more
www.insights10.com
About
Lifesciences Market
Research Reports you
can trust
A large database of over 30,000 syndicated market research reports in pharmaceuticals and healthcare sector at global, regional as well as country level. We also provide customized research reports tailor made to suit your needs
Get Insights to take
informed Business
Decisions
Insights10 is a healthcare focused market research firm founded with an aim of being an insights driven company in the data driven world and delivering actionable insights that can drive decision and strategy making process for businesses
Market Research Reports
across various domains of healthcare Pharmaceuticals
Digital
Medical
Healthcare
OTC &
Clinical
(Diseases & Drugs) Health
Devices
Services
Nutraceuticals
Trials
Market Research Reports
1
6
Full-Time Engagement
Customized Reports
2
7
Conference Coverage
Our
Primary Research
3
Services
8
Competitive Intelligence
Strategic Research Projects
4
9
Regulatory Compliance
Database Services
5
10
Report Subscription Services
Our Research Process
01
02
03
04
05
Identification of
Market
Collection of
Collaboration
Verification &
Data
Dynamics
Data
of Data
Analysis
Statistical Databases
Company Websites/Annual Reports
Data
Sources
Trade Publications
We have access to multiple highly Online Databases
reliable free and subscription data sources. We have many years of
experience to understand which
Published Research Reports
sources are more dependable for what and which to prefer for the reliable and Whitepapers
latest information.
Press Releases of Key Market Players
Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
Research Projects Done
Project Leadership Team
Dr. Purav Gandhi
Mukesh Nayak
Ritu Baliya
Dhruv Joshi
Founder & CEO
Head - Marketing
Engagement Manager
Consultant
Purav is a physician and an
Mukesh is an engineering graduate Ritu has over 6 years of experience in Dhruv Joshi is an engineer and has done entrepreneur with 12+ years of
with an MBA in Marketing. He is a strategy building, market assessments, Masters in Hospital Administration with experience in Healthcare & Life seasoned healthcare market
market sizing, and RWE for global MNC
over 4 years of experience in the Sciences industry spanning across research & marketing professional healthcare & biopharma clients across healthcare and life science industry. He strategy, market access, health
with a progressive experience of over diff. markets (America, Europe, Africa, has gained proficiency in market
informatics and RWE, Digital
20 years in Life Sciences, Pharma APAC and Middle East). Her areas of research, market assessment, and
Healthcare, analytics and data science.
and Medical Device sectors . With an expertise include: Indentifying emerging developing insights from it. He has Purav studied medicine from Gujarat in-depth understanding of primary trends in life sciences industry, worked on various consulting projects University and also completed his MBA research, he has conducted
Competitor landscape assessment,
across different geographies including from IIM-Kozhikode. Purav started his hundreds of interviews of various Disease opportunity assessments etc.
Asia, Europe, US, MENA. He has been career with Deloitte working on strategy stakeholders in pharma & healthcare She is a pro in secondary and primary aligned in working for sector reports of consulting engagements and also co-
& completed several research
research with a deep domain expertise various geographies along with market founded ConvergeHealth by Deloitte.
projects across life sciences industry.
in healthcare sector.
sizing and forecasting.
7 years of experience working with leading organizations in pharma, MedTech and healthcare domain. Some of our recent clients are mentioned below
… and many more
We would be happy to help.
Web: www.insights10.com
Email: insights@insights10.com Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
